ConductScience.org, home

Paper348666

An in vitro model of the urinary bladder.

Greenwood D and 1 other. J Antimicrob Chemother, 1978. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An in vitro model of the urinary bladder. Papers, record 348666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/348666

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An in vitro model of the urinary bladder.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greenwood DD
2O'Grady FF

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Urinary BladderMajor topic
Anti-Bacterial Agents
Bacteria
Bacterial Infections
Culture Media
Drug Interactions
Escherichia coli
Models, Biological
Nephelometry and Turbidimetry
Proteus mirabilis

Source PubMed

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
41,009,754Catheter-Associated Urinary Tract Infections: Understanding the Interplay Between Bacterial Biofilm and Antimicrobial Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41009754PubMed
39,766,591Dynamic In Vitro PK/PD Infection Models for the Development and Optimisation of Antimicrobial Regimens: A Narrative Review.Antibiotics (Basel)2024https://conductscience.org/library/papers/39766591PubMed
39,313,789Advances in experimental bladder models: bridging the gap between in vitro and in vivo approaches for investigating urinary tract infections.BMC Urol2024https://conductscience.org/library/papers/39313789PubMed
36,304,894An in vitro bladder model with physiological dynamics: Vesicoureteral reflux alters stent encrustation pattern.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36304894PubMed
34,943,697Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches.Antibiotics (Basel)2021https://conductscience.org/library/papers/34943697PubMed
14,742,182Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14742182PubMed
7,399,711An in vitro model for assessing optimum antibiotic dosage in urinary tract infection.Infection1980https://conductscience.org/library/papers/7399711PubMed
7,044,399Urinary tract infection.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7044399PubMed
7,040,252Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.Infection1982https://conductscience.org/library/papers/7040252PubMed
7,028,634The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate.Infection1981https://conductscience.org/library/papers/7028634PubMed
7,019,321Factors influencing the establishment and spread of R-plasmids in an experimental model of urinary tract infection.J Hyg (Lond)1981https://conductscience.org/library/papers/7019321PubMed
6,995,346The significance of bacterial kinetic examinations for an adequate dosage of antibiotic.Infection1980https://conductscience.org/library/papers/6995346PubMed
6,994,635Comparison of amoxicillin and ampicillin activities in a continuous culture model of the human urinary bladder.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6994635PubMed
6,993,366Response of Escherichia coli to Beta-lactam antibiotics: effect of the concomitant presence of staphylococci exhibiting inducible Beta-lactamase activity.Infection1980https://conductscience.org/library/papers/6993366PubMed
6,489,325Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6489325PubMed
6,402,522Semiautomated determination of minimum bactericidal concentrations of antibiotics.J Clin Pathol1983https://conductscience.org/library/papers/6402522PubMed
6,252,829Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252829PubMed
3,980,092In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions.Infect Immun1985https://conductscience.org/library/papers/3980092PubMed
3,531,023Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis.Infection1986https://conductscience.org/library/papers/3531023PubMed
3,325,431Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis.Infection1987https://conductscience.org/library/papers/3325431PubMed

See all 24 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/348666

GET https://conductscience.org/api/papers/v1/348666/cited_by?page=2